Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster vaccination responses in UK toddlers
ISRCTN84763401Phase 4Completed
- Sponsor
- Health Protection Agency (UK)
- Start
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label, single-arm trial of Hib-MenC-TT, pneumococcal 13-valent conjugate vaccine, measles, mumps and rubella vaccine (live) and M-M-R II in Haemophilus influenzae type b disease (Hib), meningococcal group C disease, pneumococcal disease and 3 more, sponsored by Health Protection Agency (UK). Started Feb 2013; status: completed.
02
Drugs
Hib-MenC-TTpneumococcal 13-valent conjugate vaccinemeasles, mumps and rubella vaccine (live)M-M-R II
03
Conditions
Haemophilus influenzae type b disease (Hib)meningococcal group C diseasepneumococcal diseasemeaslesmumps
Beyond the preview
Go deeper on ISRCTN84763401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84763401.